Wells Fargo raised the firm’s price target on Omnicell (OMCL) to $37 from $35 and keeps an Overweight rating on the shares following the company’s improved guidance outlook. While tariff risks remain fluid, the firm believes trade talks will likely steer outcomes toward the lower end of the risk range, supporting a more optimistic stance.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMCL:
- Omnicell’s Enhanced Profitability and Strategic Initiatives Drive Buy Rating with Increased Price Target
- Omnicell Updates 2025 Guidance and Stock Buyback Plan
- Omnicell announces new $75M share repurchase program
- Omnicell narrows FY25 EPS view to $1.30-$1.65 from $1.00-$1.65
- Omnicell raises Q2 EPS view to 24c-34c from 19c-32c, consensus 25c